“Novel FrostBite™ Cryoablation Technology for the Treatment of Pancreatic Cancer Wins NIH SBIR Phase II Award” (view this press release on 24-7 PressRelease)
“SmartThaw and RevitalICE Featured at International Conference 2017“
“CPSI Scientists Present at ISBiotech 2017“
“US Patent issued for new multi-functional thermal ablation device”
“Presentations at CRYO2016 Feature CPSI’s FrostBite GI Cancer Cryoablation Platform“
“CPSI researchers present a scientific poster on the SmartThaw™ cell thawing system“
“CPSI’s SCN Cryoablation System Highlighted in New Medical Text”
“News Segment Features CPSI’s FrostBite Cancer Treatment Device“
“CPSI Develops New Device to Treat Esophageal and Pancreatic Cancer“
“Joint white paper effort by CPSI and Eppendorf highlights the impact of handling and storage on sample quality following cryopreservation“ (view this press release on Digital Journal)
“SmartThaw Featured at ISBiotech Spring Meeting with Exhibit and Presentation”
“US Patent Issued on CPSI’s Engineered Tissue Model Platform” (view this press release on Digital Journal)
“Two US Patents Issued on the Supercritical Nitrogen (SCN) Cryoablation Platform” (view this press release on Digital Journal)
“CPSI Announces SmartThaw Prelaunch and Presents at ISBiotech Conference”
“Multi-Institutional Paper Highlights the Destructive Benefits of Cryoablation”
“CPSI Receives US Patent Allowance on Cryomedical Injection Device”
“CPSI Biotech Welcomes Congressman Reed”
“Binghamton Research Group Develops New Cancer Treatment”
To reach our public relations department, please email us or telephone 607.687.8701